Floatz logo

PHYTONADIONE, (E)-(±)-

Relapsing-Remitting Multiple Sclerosis

BiogenSmall moleculePhase 4 / ApprovedDormant
BBB
75/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
66/ 100
Competitive Position
89/ 100

Competitive context

80 Active assets in the Relapsing-Remitting Multiple Sclerosis cohort.

Asset / SponsorPhaseRating
Fingolimod
TG Therapeutics, Inc.
Phase 4A
Natalizumab
Biogen
Phase 4BBB
Glatiramer
University Hospital, Montpellier
Phase 4BBB
Interferon ?1 (human fibroblast protein moiety)
Biogen
Phase 4BBB
Ocrevus
Biocad
Phase 4BBB

View all 50 →

Same molecule, other indications

PHYTONADIONE, (E)-(±)- is also rated in:

esophageal varices with bleedingDormant
BB
Indicative ·
69 / 100
View asset →
Upper Gastrointestinal Bleeding (UGIB)Dormant
BB
Indicative ·
65 / 100
View asset →
cirrhosis of liverDormant
B
Indicative ·
59 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →